Privia Health Group, Inc.
For the period ended Sep 30, 2026. Filed Nov 5, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2026 · Filed Nov 5, 2026
PRVA$24.37-0.7%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Cash Flows
(in thousands)
| For the Nine Months Ended September 30, | ||
|---|---|---|
| 2026 | 2025 | |
| Cash flows from operating activities | ||
| Net income | $28,038 | $19,141 |
| Adjustments to reconcile net income to net cash (used in) provided by operating activities: | ||
| Depreciation | 432 | 580 |
| Amortization of intangibles | 9,708 | 6,670 |
| Stock-based compensation | 55,349 | 55,616 |
| Deferred income taxes, net | 3,888 | 9,337 |
| Changes in asset and liabilities: | ||
| Accounts receivable, net | (221,800) | (176,544) |
| Prepaid expenses and other current assets | 721 | (3,038) |
| Other non-current assets and right-of-use assets | (1,806) | 2,345 |
| Accounts payable and accrued expenses | 2,949 | 2,682 |
| Provider liability | 102,102 | 118,815 |
| Operating lease liabilities | (1,509) | (1,187) |
| Other long-term liabilities | 2,500 | 1,487 |
| Net cash (used in) provided by operating activities | (19,428) | 35,904 |
| Cash from investing activities | ||
| Business acquisitions, net of cash acquired | (11,430) | (89,058) |
| Other | (1,128) | (1,200) |
| Net cash used in investing activities | (12,558) | (90,258) |
| Cash flows from financing activities | ||
| Proceeds from exercised stock options | 7,468 | 4,557 |
| Repurchase of non-controlling interest | (11,444) | — |
| Proceeds from non-controlling interest | 2,560 | — |
| Net cash (used in) provided by financing activities | (1,416) | 4,557 |
| Net decrease in cash and cash equivalents | (33,402) | (49,797) |
| Cash and cash equivalents at beginning of period | 479,685 | 491,149 |
| Cash and cash equivalents at end of period | $446,283 | $441,352 |
| Supplemental disclosure of cash flow information: | ||
| Interest paid | $288 | $188 |
| Income taxes paid | $14,136 | $5,771 |
| Supplemental disclosure of non-cash operating activities: | ||
| Lease liabilities obtained in exchange for right-of-use assets | $234 | $1,832 |
| Contingent consideration payable | $1,270 | $— |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.